France – Pharmaceutical products – SPECIFIC CONTRACT 2026 INTERMEDIATE MEDICINES 1
This consultation concerns the supply of medicines on behalf of the establishments that are members of GCS Pharma Hauts de France. The technical characteristics of the supplies must comply with the requirements defined by the
Opportunity description
This consultation concerns the supply of medicines on behalf of the establishments that are members of GCS Pharma Hauts de France. The technical characteristics of the supplies must comply with the requirements defined by this consultation letter. ILOPROST INJECTABLE LACOSAMIDE INJECTABLE FORM DALBAVANCIN HYDROCHLORIDE Procedure: oth-mult. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.